Traversa Therapeutics (La Jolla, CA) a discovery and development stage focused on RNAi delivery closed a $2M Series A financing. Participants include San Diego Tech Coast Angels, Mesa Verde Venture Partners and Morningside Group.
Fatal error: Call to undefined function php() in /home/onbiovcc/public_html/wp-content/themes/bx-blue-green/single.php on line 25
